SCHEMBL7220878

SCHEMBL7220878

Cc1coc(C=NO)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220874 0.74
SCHEMBL24325670 0.74
SCHEMBL7220875 0.74
SCHEMBL26752689 0.74
SCHEMBL17988358 0.65 MAPT (0.39)
SCHEMBL7349983 0.62
SCHEMBL7349985 0.62
SCHEMBL10920917 0.62
SCHEMBL2161647 0.62 HTT (0.48)
SCHEMBL2161643 0.62 HTT (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503898-B1 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-01-07 US disclosed
CN-1029964-C Novel N-(4-piperidinyl) Bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-10-11 CN disclosed
EP-0295742-B1 NOVEL N-(4-PIPERIDINYL) BICYCLIC CONDENSED 2-IMIDAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-26 EP disclosed
US-4897401-A N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases JANSSEN PHARMACEUTICAL N.V. (BE) 1990-01-30 US disclosed
CN-88103784-A N- (4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives 1988-12-28 CN disclosed
EP-0295742-A1 Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-21 EP disclosed